Joseph Pergolizzi, Jr., MD, MBA

Cheif R&D
Enalare Therapeutics
Naples, Florida

Dr. Joseph V. Pergolizzi, Jr., MD, MBA is an internationally recognized thought leader in internal, perioperative and pain medicine, as well as critical and palliative care, pharmacology, drug development and regulatory affairs. He is highly published in top-tier journals. He serves as the Chief Research and Development Officer for Enalare Therapeutics

Presentation(s):

• P-098 - (Poster #98) Bedside Suite of Aggregated Technologies to Monitor and Characterize Post-operative Respiratory Depression in the Clinical and Research Milieu – The Data Acquisition Module (DAM)

  Thursday, September 4, 2025
  4:00 PM - 5:30 PM PST

• P-028 - (Poster #28) e-Delphi Consensus Study for Defining, Evaluating, and Managing Postoperative Respiratory Depression (PORD)

  Thursday, September 4, 2025
  4:00 PM - 5:30 PM PST

• P-065 - (Poster #65) Fentanyl’s Physicochemistry Influences its Unique Pharmacology and Abuse

  Thursday, September 4, 2025
  4:00 PM - 5:30 PM PST

• P-052 - (Poster #52) Observations from a Rat Model of Fentanyl-Induced Changes Respiratory Function

  Thursday, September 4, 2025
  4:00 PM - 5:30 PM PST

• P-064 - (Poster #64) Stretching the Limits of Naloxone: Sufentanil and Naloxone-Resistant Contaminants in the Illicit Drug Supply

  Thursday, September 4, 2025
  4:00 PM - 5:30 PM PST

• P-066 - (Poster #66) Summary of Traditional and an Innovative Approach for Mitigation of Postoperative Respiratory Depression

  Thursday, September 4, 2025
  4:00 PM - 5:30 PM PST